Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Cancer Survivors 1

Interventions

Specimen Handling 321 Magnetic Resonance Spectroscopy 275 pembrolizumab 267 Carboplatin 190 Cyclophosphamide 185 Biopsy 178 Cisplatin 164 Gemcitabine 139 Paclitaxel 137 Bevacizumab 123 fludarabine 122 Nivolumab 117 Radiotherapy 113 Oxaliplatin 94 venetoclax 92 Docetaxel 90 Fluorouracil 88 Capecitabine 88 Dexamethasone 85 Drug Therapy 76 Pemetrexed 75 Rituximab 73 durvalumab 71 Leucovorin 71 Blood Specimen Collection 70 Radiosurgery 69 Standard of Care 67 atezolizumab 64 Doxorubicin 64 Radiation 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Apolipoproteins E × 90 days × Clear all

NCT06334354 2026-05-14

TRAC

Memorial Sloan Kettering Cancer Center

Breast Cancer Survivors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡